MAIA (MAIA Biotechnology, Inc.) Stock Analysis - Analyst Ratings

MAIA Biotechnology, Inc. (MAIA) is a publicly traded Healthcare sector company. As of May 21, 2026, MAIA trades at $1.29 with a market cap of $76.61M and a P/E ratio of -1.82. MAIA moved +3.66% today. Year to date, MAIA is -14.57%; over the trailing twelve months it is -29.12%. Its 52-week range spans $0.87 to $3.48. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces MAIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MAIA?

1 analysts cover MAIA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.00.

MAIA Key Metrics

Key financial metrics for MAIA
MetricValue
Price$1.29
Market Cap$76.61M
P/E Ratio-1.82
EPS$-0.70
Dividend Yield0.00%
52-Week High$3.48
52-Week Low$0.87
Volume448.00K
Avg Volume0
Revenue (TTM)$0
Net Income$-22.40M
Gross Margin0.00%

MAIA Analyst Consensus

1 analysts cover MAIA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.

Latest MAIA News

Recent MAIA Insider Trades

  • Smith Stan bought 57.19K (~$70.00K) on Dec 22, 2025.
  • CHAOUKI STEVEN M bought 40.85K (~$50.00K) on Dec 22, 2025.
  • Louie Ngar Yee bought 81.70K (~$100.00K) on Dec 22, 2025.

Common questions about MAIA

What do analysts rate MAIA?
1 analysts cover MAIA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.00.
Does Rallies show MAIA price targets?
Yes. Rallies tracks MAIA analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MAIA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MAIA. It does not provide personalized investment advice.
MAIA

MAIA